Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.22 SEK | -3.59% | +9.34% | -57.96% |
Apr. 15 | Oncopeptides AB Secures National Reimbursement for Pepaxti in Spain | CI |
Apr. 04 | Oncopeptides AB Provides Sales Guidance for the First Quarter of 2024 | CI |
Chart calendar Oncopeptides AB
Upcoming events on Oncopeptides AB
Past events on Oncopeptides AB
2024-05-03 02:00 am | Q1 2024 Earnings Release |
2024-03-20 06:30 am | Redeye Theme: Commercialization in Life Science |
2024-02-27 03:00 am | Q4 2023 Earnings Call |
2024-02-27 02:00 am | Q4 2023 Earnings Release |
2024-01-24 07:07 am | Redeye Theme: Fight Cancer |
2023-11-08 03:00 am | Q3 2023 Earnings Call |
2023-11-08 02:00 am | Q3 2023 Earnings Release |
2023-08-10 03:00 am | Q2 2023 Earnings Call |
2023-08-10 02:00 am | Q2 2023 Earnings Release |
2023-05-25 09:00 am | Annual General Meeting |
2023-05-04 03:00 am | Q1 2023 Earnings Call |
2023-05-04 02:00 am | Q1 2023 Earnings Release |
2023-02-16 03:00 am | FY 2022 Earnings Call |
2023-02-16 02:00 am | FY 2022 Earnings Release |
2022-12-09 | American Society of Hematology Meeting - Poster No. 4799 |
2022-12-09 | American Society of Hematology Meeting - Poster No. 2673 |
2022-12-09 | American Society of Hematology Meeting - Abstract No. 5776 |
2022-12-09 | American Society of Hematology Meeting - Poster No. 4800 |
2022-11-22 | SEB Healthcare Seminar |
2022-11-09 08:00 am | Q3 2022 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 7,60 - | 118 156 -24.22% | 8,36 6,88 21.53% | 35,2 38,8 -9.31% | 82,4 |
EBITDA Million SEK | Released Forecast Spread | -735 -678 -8.39% | -1 577 -1 495 -5.51% | -1 400 -1 411 0.81% | -332 -319 -4.15% | 0,00 -241 - | -286 |
EBIT Million SEK | Released Forecast Spread | -739 -685 -7.97% | -1 591 -1 494 -6.5% | -1 421 -1 331 -6.72% | -349 -319 -9.53% | -253 -234 -8.51% | -238 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -740 -684 -8.16% | -1 592 -1 495 -6.54% | -1 421 -1 332 -6.7% | -338 -319 -5.87% | -248 -236 -5.26% | -244 |
Net income Million SEK | Released Forecast Spread | -741 -684 -8.25% | -1 595 -1 481 -7.7% | -1 430 -1 302 -9.85% | -338 -319 -5.95% | -249 -236 -5.54% | -244 |
EPS SEK | Released Forecast Spread | -14,3 -13,6 -5.76% | -25,6 -23,3 -9.75% | -19,0 -17,9 -6.31% | -4,11 -3,63 -13.13% | -2,76 -2,07 -33.18% | -1,53 |
Announcement Date | 20/02/20 | 18/02/21 | 17/02/22 | 16/02/23 | 24/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 |
---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | -21,7 32,6 -166.63% | 0,00 22,7 - | 8,75 0,00 - | 0,00 0,00 - |
EBIT Million SEK | Released Forecast Spread | -390 -168 -131.88% | -98,9 -162 39.11% | -61,1 -66,0 7.38% | -88,9 -59,7 -48.79% |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -389 -168 -131.67% | -98,6 -162 39.28% | -59,6 -66,0 9.7% | -88,3 -59,7 -47.91% |
Net income Million SEK | Released Forecast Spread | -394 -168 -134.35% | -98,6 -162 39.28% | -59,8 -66,0 9.28% | -88,4 -59,7 -48.1% |
EPS SEK | Released Forecast Spread | -5,23 -2,22 -135.59% | -1,31 -2,15 39.07% | -0,79 -0,87 9.2% | -1,00 -0,72 -38.89% |
Announcement Date | 17/02/22 | 04/05/22 | 11/08/22 | 09/11/22 |
Today 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-14 | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-15 | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 09:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-07-23 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-25 01:00 am | ARGENX SE: Q2 2024 Earnings Release |
2024-07-29 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-29 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-29 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Oncopeptides AB
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ONCO Stock
- Calendar Oncopeptides AB